Biogen Inc. (ETR:IDP)
Germany · Delayed Price · Currency is EUR 121.35
-1.70 (-1.38%)
Sep 19, 2025, 5:35 PM CET
Biogen Market Cap
Biogen has a market cap or net worth of €17.79 billion as of September 19, 2025. Its market cap has decreased by -33.97% in one year.
Market Cap
17.79B
Enterprise Value
21.05B
Revenue
8.51B
Ranking
n/a
PE Ratio
13.65
Stock Price
€121.35
Market Cap Chart
Since September 17, 1991, Biogen's market cap has increased from 126.71M to 17.79B, an increase of 13,937.79%. That is a compound annual growth rate of 15.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2025 | 17.79B | -17.36% |
| Dec 31, 2024 | 21.52B | -36.55% |
| Dec 29, 2023 | 33.92B | -9.09% |
| Dec 30, 2022 | 37.31B | 20.41% |
| Dec 31, 2021 | 30.99B | 0.60% |
| Dec 31, 2020 | 30.80B | -35.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Siemens Healthineers AG | 52.68B |
| Merck KGaA | 46.72B |
| Bayer Aktiengesellschaft | 27.07B |
| Fresenius SE & Co. KGaA | 26.48B |
| Sartorius Aktiengesellschaft | 12.96B |
| Fresenius Medical Care AG | 12.53B |
| Fielmann Group AG | 4.33B |
| Carl Zeiss Meditec AG | 3.94B |